Date Filed | Type | Description |
10/10/2023 |
8-K
| Quarterly results |
08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/10/2023 |
8-K/A
| Quarterly results |
08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/08/2023 |
8-K
| Quarterly results |
07/24/2023 |
8-K
| Quarterly results |
05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/09/2023 |
8-K
| Quarterly results |
05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/03/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even... |
03/09/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/02/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
03/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/28/2023 |
8-K
| Quarterly results |
02/14/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
|
"ab UBS Bank USA Credit Line Agreement Variable Credit Line Account Number: Fixed Credit Line Account Number: Internal Use Only Credit Line Agreement - Demand Facility THIS CREDIT LINE AGREEMENT is made by and between the party or parties signing as the Borrower on the Application to which this Agreement is attached and UBS Bank USA and, together with the Application, establishes the terms and conditions that will govern the uncommitted demand loan facility made available to the Borrower by the Bank and any letter of credit which may be issued by the Bank in its sole and absolute discretion at the request of the Borrower, whether or not the Borrower is identified therein as the account party. This Agreement becomes effective upon the earlier of the date of notice from the Bank to the Borrow...",
"Supernus Enters Into $150 Million Credit Facility ROCKVILLE, MD, February 14, 2023 – Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced it entered into a credit line agreement with UBS Bank USA providing the Company an uncommitted demand secured line of credit of up to $150 million, which can be drawn at any time. Any fixed rate borrowing will bear interest at a fixed interest rate, equal to the sum of the UBS Fixed Funding Rate plus the applicable Percentage Spread established in the Credit Line. Any variable rate borrowing will bear interest at a variable interest rate, equal to the sum of the UBS Variable Rate plus the applicable Percentage Spread establishe..." |
|
02/14/2023 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 8.1% stake in SUPERNUS PHARMACEUTICALS, INC. |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.7% stake in Supernus Pharmaceuticals Inc. |
02/08/2023 |
5
| NEWHALL CHARLES W III (Director) has filed a Form 5 on SUPERNUS PHARMACEUTICALS, INC. |
01/23/2023 |
SC 13G/A
| BlackRock Inc. reports a 17.8% stake in SUPERNUS PHARMACEUTICALS INC |
11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/08/2022 |
8-K
| Quarterly results |
10/25/2022 |
8-K
| Quarterly results |
10/11/2022 |
8-K
| Other Events Interactive Data |
08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/04/2022 |
8-K
| Quarterly results |
07/26/2022 |
8-K
| Quarterly results |
06/17/2022 |
8-K
| Quarterly results |
06/09/2022 |
8-K
| Quarterly results |
05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/10/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
05/09/2022 |
8-K
| Quarterly results |
|